NCT00025311View on ClinicalTrials.gov

Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Primary Completion Date

October 31, 2003

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

topotecan hydrochloride

Trial Locations (3)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10032

Herbert Irving Comprehensive Cancer Center, New York

75651

CHU Pitie-Salpetriere, Paris

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00025311 - Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain | Biotech Hunter | Biotech Hunter